BioSpace News Archive

Business

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd’s patented low dose naltrexone combo product(s) worldwide.

December 13, 2023
·
4 min read
Biotech Bay

Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders

Encellin announced the closing of a $9.9M financing round led by Khosla Ventures, with participation from Y Combinator.

December 13, 2023
·
3 min read
BioMidwest

University Hospital Birmingham Improves Craniomaxillofacial Tumor Surgery Using 3D Printed Tailored Surgical Guides

Stratasys Ltd. (Nasdaq: SSYS) (“Stratasys” or the “Company”), a leader in polymer 3D printing solutions, has shared that the University Hospital Birmingham in England is delivering improved outcomes for head and neck cancer patients.

December 13, 2023
·
5 min read
Pharm Country

SELLAS to Host Corporate Update Webinar on January 3, 2024 at 8:30 am ET

SELLAS Life Sciences Group, Inc. today announced that it will host a corporate update webinar on Wednesday, January 3, 2024, at 8:30 a.m. Eastern Time.

December 13, 2023
·
3 min read
Drug Development

Avidity Biosciences Reports Positive Data Demonstrating AOC 1044 Delivers Unprecedented Concentrations of PMO in Muscle Following a Single Dose in Healthy Volunteers

Avidity Biosciences today announced positive AOC 1044 data in healthy volunteers from the Phase 1/2 EXPLORE44™ clinical trial for the treatment of Duchenne muscular dystrophy mutations amenable to exon 44 skipping (DMD44).

December 13, 2023
·
10 min read
Genetown

Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List

Paratek Pharmaceuticals, Inc. today announced that China’s National Healthcare Security Administration (NHSA) has added the oral formulation of NUZYRA® (omadacycline) to the country’s National Reimbursement Drug List (NRDL) for treatment of community-acquired bacterial pneumonia.

December 13, 2023
·
2 min read
Drug Development

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that it has initiated its international confirmatory Phase 3 RAMP 301 trial.

December 13, 2023
·
13 min read
Immunocan Provides Update on Business Operations, Highlighting Launch of New Gene-edited Mice Generating Fully Human Heavy-chain-only Antibodies and Advances in Partner Pipeline

Shanghai Immunocan Biotech Co., Ltd. announces the launch of its ImmuMab Heavy® mice.

December 13, 2023
·
3 min read
Inovedis Announces First Patients Treated with the SINEFIX™ Rotator Cuff Repair System

Inovedis GmbH today announced that the first two patients were treated with the SINEFIX™ Rotator Cuff Repair System as part of a pre-market clinical study in Tübingen, Germany.

December 13, 2023
·
2 min read
Biotech Bay

Alveo Technologies Announces Major Distribution Expansion Across EMEA

Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced 19 new distributor partnerships across Europe, Africa, and the Middle East.

December 13, 2023
·
3 min read